Related Experiment Video

Updated: Jun 28, 2025

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

1.7K

Inactivation of VRK1 sensitizes ovarian cancer to PARP inhibition through regulating DNA-PK stability

Do Yeon Kim1, Hyeseon Yun1, Ji-Eun You1

  • 1Asan Institute for Life Science, Asan Medical Center, Seoul 05505, Republic of Korea; Department of Pharmacology, AMIST, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Experimental Cell Research
|April 13, 2024
PubMed

Insights

Vaccinia-related kinase-1 (VRK1) is highly expressed in ovarian cancer. Inhibiting VRK1 enhances cancer cell death and sensitivity to PARP inhibitors, suggesting VRK1 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer is a leading cause of gynecologic cancer mortality.
  • Synthetic lethality is a promising anti-cancer strategy involving synergistic gene mutations.
  • Vaccinia-related kinase-1 (VRK1) is linked to DNA damage repair, but its role in ovarian cancer is unclear.

Purpose of the Study:

  • To investigate the role of VRK1 in ovarian cancer progression and its potential as a therapeutic target.
  • To explore VRK1's impact on DNA damage response and sensitivity to PARP inhibitors.

Main Methods:

  • Analysis of VRK1 expression in ovarian tumors.
  • VRK1 knockdown experiments to assess effects on apoptosis and cell cycle.
  • Investigation of VRK1's role in DNA damage repair pathways, including non-homologous end joining (NHEJ).
  • Assessment of VRK1 knockdown combined with olaparib (a PARP inhibitor) treatment in ovarian cancer cell lines.

Main Results:

  • High VRK1 expression was observed in ovarian tumors.
  • VRK1 depletion induced apoptosis and cell cycle arrest, increasing DNA damage and genomic instability.
  • VRK1 knockdown destabilized DNA-PK, inhibiting NHEJ and enhancing sensitivity to olaparib, particularly in high VRK1-expressing cells.

Conclusions:

  • VRK1 is a potential biomarker for predicting sensitivity to PARP inhibitors in ovarian cancer.
  • Targeting VRK1, in combination with PARP inhibitors, represents a novel synthetic lethality approach for ovarian cancer treatment.
  • This combination strategy may enhance therapeutic efficacy while potentially reducing drug toxicity.
Keywords:
DNA damageDNA-PKOvarian cancerPARP inhibitorVRK1

More Related Videos

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.2K
Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.0K

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.5K